395521005: Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\UK product\Virtual therapeutic moiety\Valsartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\UK product\Virtual therapeutic moiety\Valsartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing valsartan\Product containing valsartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing valsartan\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing valsartan\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing valsartan\Product containing hydrochlorothiazide and valsartan\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing valsartan\Product containing valsartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing valsartan\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing valsartan\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing valsartan\Product containing hydrochlorothiazide and valsartan\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing valsartan\Product containing valsartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing valsartan\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing valsartan\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing valsartan\Product containing hydrochlorothiazide and valsartan\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and valsartan\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and valsartan\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and valsartan\Valsartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and valsartan\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Product manufactured as oral dose form\Product containing valsartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet
\Medicinal product\Product manufactured as oral dose form\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3501798017 Hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

3679552013 Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

46823201000001114 Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Is a	Product containing valsartan	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has active ingredient	Valsartan	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Is a	Product containing hydrochlorothiazide	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has active ingredient	Hydrochlorothiazide	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Is a	Product containing hydrochlorothiazide and valsartan	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Is a	Product manufactured as oral dose form	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Is a	Product containing hydrochlorothiazide in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has active ingredient	Hydrochlorothiazide	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has basis of strength substance	Hydrochlorothiazide	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has presentation strength numerator value	12.5	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has active ingredient	Valsartan	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has basis of strength substance	Valsartan	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has presentation strength numerator value	160	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has basis of strength substance	Valsartan	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has presentation strength numerator value	160	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has basis of strength substance	Hydrochlorothiazide	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has presentation strength numerator value	12.5	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has precise active ingredient	Valsartan	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has precise active ingredient	Hydrochlorothiazide	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Is a	Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Is a	Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Plays role	Diuretic therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has active ingredient	Valsartan	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has active ingredient	Hydrochlorothiazide	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has manufactured dose form	Oral dose form	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	tablet.oral ontology form and route	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Oral route	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Is a	Valsartan + Hydrochlorothiazide	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has specific active ingredient	Valsartan	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has specific active ingredient	Hydrochlorothiazide	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Co-Diovan 160mg/12.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets 28 tablet	Is pack of	False	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-Diovan 160mg/12.5mg tablets (PI) (Waymade Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-Diovan 160mg/12.5mg tablets (Dowelhurst Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-Diovan 160mg/12.5mg tablets (Doncaster Pharmaceuticals Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-Diovan 160mg/12.5mg tablets (Sigma Pharmaceuticals Plc)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets 28 tablet	Has VMP	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-Diovan 160mg/12.5mg tablets (Lexon (UK) Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-Diovan 160mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-Diovan 160mg/12.5mg tablets (Necessity Supplies Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Teva UK Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Actavis UK Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Consilient Health Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Alliance Healthcare (Distribution) Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (A A H Pharmaceuticals Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Arrow Generics Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Waymade Healthcare Plc)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Milpharm Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Sandoz Ltd)	Is a	True	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3501798017	Hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3679552013	Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
46823201000001114	Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom Edition module